Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.
2.

A study of ΔNp63 expression in lung non-small cell carcinomas.

Nonaka D.

Am J Surg Pathol. 2012 Jun;36(6):895-9. doi: 10.1097/PAS.0b013e3182498f2b.

PMID:
22367298
3.

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.

Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N.

Mod Pathol. 2012 Mar;25(3):405-15. doi: 10.1038/modpathol.2011.173. Epub 2011 Nov 4.

4.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

5.

SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract.

Long KB, Hornick JL.

Hum Pathol. 2009 Dec;40(12):1768-73. doi: 10.1016/j.humpath.2009.06.006. Epub 2009 Aug 27.

PMID:
19716157
6.

Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.

Kim MJ, Shin HC, Shin KC, Ro JY.

Ann Diagn Pathol. 2013 Feb;17(1):85-90. doi: 10.1016/j.anndiagpath.2012.07.006. Epub 2012 Oct 4.

PMID:
23040737
7.

The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.

Uke M, Rekhi B, Ajit D, Jambhekar NA.

Cytopathology. 2010 Feb;21(1):56-63. doi: 10.1111/j.1365-2303.2009.00678.x. Epub 2009 Sep 9.

PMID:
19744186
8.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
10.
11.

Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas.

Owens SR, Greenson JK.

Am J Surg Pathol. 2007 Feb;31(2):285-90.

PMID:
17255774
12.
13.

P63 expression in lung carcinoma: a tissue microarray study of 408 cases.

Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB, Grimes HL.

Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):240-7.

PMID:
15551738
14.
15.

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.

Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD.

Hum Pathol. 2001 Nov;32(11):1157-65.

PMID:
11727253
16.

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI.

Am J Surg Pathol. 2012 Oct;36(10):1472-6. doi: 10.1097/PAS.0b013e318260cde7.

17.

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Terry J, Leung S, Laskin J, Leslie KO, Gown AM, Ionescu DN.

Am J Surg Pathol. 2010 Dec;34(12):1805-11. doi: 10.1097/PAS.0b013e3181f7dae3.

PMID:
21107086
18.
20.

Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.

Taniere P, Borghi-Scoazec G, Saurin JC, Lombard-Bohas C, Boulez J, Berger F, Hainaut P, Scoazec JY.

Am J Surg Pathol. 2002 Sep;26(9):1213-21.

PMID:
12218578
Items per page

Supplemental Content

Write to the Help Desk